JP2023535366A5 - - Google Patents

Info

Publication number
JP2023535366A5
JP2023535366A5 JP2023503124A JP2023503124A JP2023535366A5 JP 2023535366 A5 JP2023535366 A5 JP 2023535366A5 JP 2023503124 A JP2023503124 A JP 2023503124A JP 2023503124 A JP2023503124 A JP 2023503124A JP 2023535366 A5 JP2023535366 A5 JP 2023535366A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
sequence
acid sequence
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023503124A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535366A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/041737 external-priority patent/WO2022015922A1/en
Publication of JP2023535366A publication Critical patent/JP2023535366A/ja
Publication of JP2023535366A5 publication Critical patent/JP2023535366A5/ja
Pending legal-status Critical Current

Links

JP2023503124A 2020-07-16 2021-07-15 G12v変異を有するrasに対するhlaクラスii拘束性drb t細胞受容体 Pending JP2023535366A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063052502P 2020-07-16 2020-07-16
US63/052,502 2020-07-16
PCT/US2021/041737 WO2022015922A1 (en) 2020-07-16 2021-07-15 Hla class ii-restricted drb t cell receptors against ras with g12v mutation

Publications (2)

Publication Number Publication Date
JP2023535366A JP2023535366A (ja) 2023-08-17
JP2023535366A5 true JP2023535366A5 (enExample) 2024-07-18

Family

ID=77265247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023503124A Pending JP2023535366A (ja) 2020-07-16 2021-07-15 G12v変異を有するrasに対するhlaクラスii拘束性drb t細胞受容体

Country Status (9)

Country Link
US (1) US20230257440A1 (enExample)
EP (1) EP4182029B1 (enExample)
JP (1) JP2023535366A (enExample)
KR (1) KR20230046294A (enExample)
CN (1) CN116348484A (enExample)
AU (1) AU2021309958A1 (enExample)
CA (1) CA3185483A1 (enExample)
ES (1) ES3063075T3 (enExample)
WO (1) WO2022015922A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3209741A1 (en) 2021-02-26 2022-09-01 Shohei Koide Compositions and methods comprising antibodies that bind to covalent peptide conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034334B2 (en) 2002-09-06 2011-10-11 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
US8383099B2 (en) 2009-08-28 2013-02-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adoptive cell therapy with young T cells
AU2011304728A1 (en) * 2010-09-20 2013-03-14 Biontech Ag Antigen-specific T cell receptors and T cell epitopes
US20120244133A1 (en) 2011-03-22 2012-09-27 The United States of America, as represented by the Secretary, Department of Health and Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
ES2784261T3 (es) * 2014-11-26 2020-09-23 Us Health Receptores de células T anti-KRAS mutado
ES2879287T3 (es) * 2015-09-15 2021-11-22 Us Health Receptores de células T que reconocen KRAS mutado restringido a HLA-cw8
MX2020003117A (es) * 2017-09-20 2020-08-20 Us Health Receptores de celulas t restringidas a hla de clase ii contra ras mutado.
US11466071B2 (en) * 2017-12-04 2022-10-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services HLA class I-restricted t cell receptors against mutated RAS
EP3749349A4 (en) * 2018-02-10 2021-11-24 Berkeley Lights, Inc. MUTANT IDH1 SPECIFIC T CELL RECEPTOR

Similar Documents

Publication Publication Date Title
JP7256794B2 (ja) 変異型rasに対するhlaクラスii拘束性t細胞受容体
Spies et al. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer
AU2018259029B2 (en) TCR and peptides
Orr et al. Comparison of amino acid sequences of two human histocompatibility antigens, HLA-A2 and HLA-B7: location of putative alloantigenic sites.
RU2752528C2 (ru) Композиции и библиотеки, содержащие рекомбинантные полинуклеотиды, кодирующие Т-клеточные рецепторы, и способы применения рекомбинантных Т-клеточных рецепторов
JP2021505136A5 (enExample)
GB2609760A (en) HLA Class I-restricted T cell receptors against RAS with G12D mutation
JP2020534828A5 (enExample)
JP2022523024A5 (enExample)
Takamiya et al. HLA-B* 3501–peptide interactions: role of anchor residues of peptides in their binding to HLA-B* 3501 molecules
JP2023534241A5 (enExample)
JP7742354B2 (ja) G12v変異を有するrasに対するhlaクラスii拘束性t細胞受容体
CN120607607A (zh) 针对含有g12r突变的ras的hla第ii类限制性t细胞受体
JP2023534241A (ja) G12d変異を有するrasに対するhlaクラスii拘束性drb t細胞受容体
Wagner et al. Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1
JP2023540123A5 (enExample)
TWI900647B (zh) 識別p53中r273c或y220c突變的t細胞受體
JP2023535366A (ja) G12v変異を有するrasに対するhlaクラスii拘束性drb t細胞受容体
US8658177B2 (en) Promiscuous HER-2/Neu CD4 T cell epitopes
Hayball et al. The immune function of MHC class II molecules mutated in the putative superdimer interface
US20230312672A1 (en) Hla class i-restricted t cell receptors against cd20
NZ805541A (en) Hla class i-restricted t cell receptors against mutated ras
EA045621B1 (ru) T-клеточные рецепторы, рестриктированные по антигену лейкоцитов человека класса ii, против мутантного ras